1. Home
  2. LIVE vs CTSO Comparison

LIVE vs CTSO Comparison

Compare LIVE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

N/A

Current Price

$9.98

Market Cap

30.3M

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.73

Market Cap

49.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIVE
CTSO
Founded
1968
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
49.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIVE
CTSO
Price
$9.98
$0.73
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
6.0K
123.7K
Earning Date
12-11-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$443,794,000.00
$36,979,520.00
Revenue This Year
N/A
$11.93
Revenue Next Year
N/A
$21.22
P/E Ratio
$22.68
N/A
Revenue Growth
N/A
23.89
52 Week Low
$6.25
$0.60
52 Week High
$25.88
$1.61

Technical Indicators

Market Signals
Indicator
LIVE
CTSO
Relative Strength Index (RSI) 41.92 45.97
Support Level $9.05 $0.70
Resistance Level $12.49 $0.85
Average True Range (ATR) 0.98 0.07
MACD 0.28 0.01
Stochastic Oscillator 47.36 49.56

Price Performance

Historical Comparison
LIVE
CTSO

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: